Ad is loading...
EKWCX
Price
$54.06
Change
+$0.54 (+1.01%)
Updated
Nov 22 closing price
FSAGX
Price
$27.91
Change
+$0.21 (+0.76%)
Updated
Nov 22 closing price
Ad is loading...

EKWCX vs FSAGX

Header iconEKWCX vs FSAGX Comparison
Open Charts EKWCX vs FSAGXBanner chart's image
Allspring Precious Metals C
Price$54.06
Change+$0.54 (+1.01%)
VolumeN/A
CapitalizationN/A
Fidelity Select Gold
Price$27.91
Change+$0.21 (+0.76%)
VolumeN/A
CapitalizationN/A
EKWCX vs FSAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EKWCX vs. FSAGX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKWCX is a Buy and FSAGX is a Buy.

FUNDAMENTALS
Fundamentals
FSAGX has more cash in the bank: 1.6B vs. EKWCX (374M). FSAGX pays higher dividends than EKWCX: FSAGX (0.97) vs EKWCX (0.00). EKWCX was incepted earlier than FSAGX: EKWCX (27 years) vs FSAGX (39 years). FSAGX is a more actively managed with annual turnover of: 46.00 vs. EKWCX (9.00). FSAGX has a lower initial minimum investment than EKWCX: FSAGX (0) vs EKWCX (1000). EKWCX annual gain was more profitable for investors over the last year : 38.13 vs. FSAGX (34.46). EKWCX return over 5 years is better than : 50.77 vs. FSAGX (37.29).
EKWCXFSAGXEKWCX / FSAGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years39 years-
Gain YTD29.70225.227118%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets374M1.6B23%
Annual Yield % from dividends0.000.97-
Returns for 1 year38.1334.46111%
Returns for 3 years22.425.69394%
Returns for 5 years50.7737.29136%
Returns for 10 years82.3170.76116%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRVL92.943.08
+3.43%
Marvell Technology
GORV0.950.02
+2.14%
Lazydays Holdings
TKR75.221.28
+1.73%
Timken Company (The)
CTS53.180.43
+0.82%
CTS Corp
NPCE9.00-0.19
-2.07%
Neuropace